Literature DB >> 24878218

C-reactive protein level in morbidly obese patients before and after bariatric surgery.

M E Rojano-Rodríguez1, C Valenzuela-Salazar2, L E Cárdenas-Lailson1, L S Romero Loera1, M Torres-Olalde1, M Moreno-Portillo1.   

Abstract

BACKGROUND: Human obesity is associated with a proinflammatory state and an elevated level of mediators, such as C-reactive protein (CRP).
OBJECTIVES: To establish CRP levels as baseline preoperative values and then at 6 months after bariatric surgery, as well as to determine the changes in weight, body mass index (BMI), leukocytes, and glycemia.
MATERIALS AND METHODS: An observational, analytical, retrospective, longitudinal, and open study was conducted. Serum CRP values were measured in 36 adults presenting with morbid obesity, and their baseline relation to weight, BMI, leukocytes, and glycemia was determined; the relation to the same parameters was established again, 6 months after bariatric surgery.
RESULTS: The mean and standard deviation of preoperative and postoperative CRP (mg/L) was 1.15±0.86 and 0.34±0.28, respectively with p<0.0001; weight (kg) 112.10±22.91 and 84.82±17.11, p=0.0443; BMI (kg/m(2)) 42.48±5.97 and 32.2±4.79, p=0.0988; glucose (mg/dL) 100.58±17.82 and 87.11±8.49, p<0.0001, and leukocytes (× 10(3)/mm(3)) 8.62±1.69 and 6.99±1.56, p=0.3192. Baseline CRP only correlated with weight and BMI (p=0.047 and p=0.027 respectively) and there was no correlation between postoperative CRP and the evaluated parameters.
CONCLUSIONS: Preoperative CRP had a significant lineal relation to weight and body mass index. Patients who underwent bariatric surgery had a significant decrease in CRP, weight, and fasting glucose at 6 months after surgery.
Copyright © 2013 Asociación Mexicana de Gastroenterología. Published by Masson Doyma México S.A. All rights reserved.

Entities:  

Keywords:  Bariatric surgery; C-reactive protein; Cirugía bariátrica; Obesidad; Obesity; Proteína C reactiva

Mesh:

Substances:

Year:  2014        PMID: 24878218     DOI: 10.1016/j.rgmx.2013.11.002

Source DB:  PubMed          Journal:  Rev Gastroenterol Mex        ISSN: 0375-0906


  6 in total

1.  Bariatric Surgery Improves Renal Function: a Large Inner-City Population Outcome Study.

Authors:  Kashif Saeed; Leaque Ahmed; Paritosh Suman; Sanjiv Gray; Khuram Khan; Hector DePaz; Amrita Persaud; Bianca Passos Fox; Sara Alothman; Saqib Saeed
Journal:  Obes Surg       Date:  2020-08-20       Impact factor: 4.129

Review 2.  The immune remodel: Weight loss-mediated inflammatory changes to obesity.

Authors:  Charles L Phillips; Bernadette E Grayson
Journal:  Exp Biol Med (Maywood)       Date:  2020-01-19

3.  Intestinal barrier function in morbid obesity: results of a prospective study on the effect of sleeve gastrectomy.

Authors:  Jennifer Wilbrink; Nienke Bernards; Zlatan Mujagic; Mark van Avesaat; Kirsten Pijls; Tim Klaassen; Hans van Eijk; Simon Nienhuijs; Arnold Stronkhorst; Ellen Wilms; Freddy Troost; Ad Masclee
Journal:  Int J Obes (Lond)       Date:  2019-12-09       Impact factor: 5.095

4.  Changes of Urinary Cytokines in Non-Diabetic Obese Patients After Laparoscopic Sleeve Gastrectomy.

Authors:  Ahmed Salman; Mohamed Salman; Mohamed D Sarhan; Karim Maurice; Mohamed Tag El-Din; Ahmed Youssef; Reham Ahmed; Tarek Abouelregal; Hossam El-Din Shaaban; Ghada M K GabAllah; Mahmoud Gouda Omar
Journal:  Int J Gen Med       Date:  2021-03-10

5.  Inflammatory markers, the tryptophan-kynurenine pathway, and vitamin B status after bariatric surgery.

Authors:  Monika H E Christensen; Dag J Fadnes; Therese H Røst; Eva R Pedersen; John R Andersen; Villy Våge; Arve Ulvik; Øivind Midttun; Per M Ueland; Ottar K Nygård; Gunnar Mellgren
Journal:  PLoS One       Date:  2018-02-05       Impact factor: 3.240

Review 6.  Interplay between the Adaptive Immune System and Insulin Resistance in Weight Loss Induced by Bariatric Surgery.

Authors:  José Romeo Villarreal-Calderón; Ricardo X Cuéllar; Martín R Ramos-González; Nestor Rubio-Infante; Elena C Castillo; Leticia Elizondo-Montemayor; Gerardo García-Rivas
Journal:  Oxid Med Cell Longev       Date:  2019-12-06       Impact factor: 6.543

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.